Doç. Dr. Emre HOCA

1. Diagnostic Performance of Plasma Levels of sST2 (Soluble Suppression of Tumorigenicity 2) in the Evaluation of Hypervolemia in Hemodialysis Patients: A Comparative Analysis With Traditional and Alternative Biomarkers

Hartavi E. C., UZUN S., KARADAĞ S., HOCA E., Çelik A., Oğuz H., et al.

Hemodialysis International , cilt.30, sa.4, ss.797-806, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Diyabetik olmayan aşırı kilolu/obez yetişkinlerde insülin direncinin belirleyicileri olarak bel-boyun oranı ve TG/HDL-C oranı: Kesitsel bir çalışma

ENGİN İ., HOCA E.

Developments and experiments in health and medicine , cilt.40, sa.3, ss.379-388, 2026 (TRDizin)

3. Validity and Reliability of the Turkish Version of the Type 2 Diabetes Distress Assessment System (T2-DDAS-TR)

Bulut A., HOCA E., ATAOĞLU H. E., Şengül H., Kalayci N.

International Journal of Noncommunicable Diseases , cilt.11, sa.4, ss.387-396, 2026 (ESCI, Scopus) Sürdürülebilir Kalkınma

4. The Relationship Between Pituitary Axis Hormones and All-Cause Mortality in Hospitalized Patients with Chronic Diseases: A Prospective Cohort Study

Havare E., Topçu G., Yıldız P., HOCA E., ATAOĞLU H. E.

Medicina (Lithuania) , cilt.62, sa.3, 2026 (SCI-Expanded, Scopus)

5. Metabolic pathways are associated with increased estimated cardiovascular risk in major depressive disorder: a QRISK3-based analysis

Ceylan Hoca S., Demirel U. T., HOCA E.

Postgraduate Medicine , 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis

Urvasızoğlu A. Ö., HOCA E., CEBECİ E., UZUN S., KARADAĞ S., Öztürk S.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.81, sa.2, ss.70-79, 2026 (SCI-Expanded, Scopus)

7. The Effect of Visfatin Levels on Blood Pressure and Cardiac Risk Factors in Patients with Acromegaly

kuzu ö. f., Hoca E., Cakir E., Ataoglu H. E.

İstanbul Medical Journal , cilt.26, sa.4, ss.329-334, 2025 (ESCI, TRDizin)

8. Low Serum Uric Acid as an Independent Predictor of Mortality and Poor Prognosis: A Retrospective Cohort Study

Şahin S. İ., Çiftçi Öztürk E., Öztürk H., Çetintulum Aydın B., Ziyadanoğlu Cezairli F. P., HOCA E., et al.

Journal of Clinical Medicine , cilt.14, sa.19, 2025 (SCI-Expanded, Scopus)

9. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients

HOCA E., Cangir B., AHBAB S., Şahin S. İ., Çiftçi Öztürk E., Urvasızoğlu A. Ö., et al.

Diagnostics , cilt.15, sa.16, 2025 (SCI-Expanded, Scopus)

10. The Impact of SGLT2 Inhibitors on Hemoglobin Levels in Type 2 Diabetes: Potential Benefits Beyond Glycemic and Renal Outcomes

HOCA E., Kalayci N.

Haseki Tip Bulteni , cilt.63, sa.3, ss.141-149, 2025 (ESCI, Scopus, TRDizin)

11. The Impact of Metformin on BNP Levels: A Potential Cardioprotective Role in Type 2 Diabetes

HOCA E., Kalaycı N., AHBAB S., Engin İ., ATAOĞLU H. E.

Journal of Clinical Medicine , cilt.14, sa.8, 2025 (SCI-Expanded, Scopus)

12. The effects of chronic kidney disease stages on dyslipidemia, cardiovascular disease prevalence and mortality

HOCA E., Mermer H. B., Kula A. C., AHBAB S., ATAOĞLU H. E.

Northern Clinics of Istanbul , cilt.12, sa.1, ss.95-102, 2025 (ESCI, Scopus, TRDizin)

13. Comparison of Controlling Nutritional Status Score with Bedside Index for Severity in Acute Pancreatitis Score and Atlanta Classification for Mortality in Patients with Acute Pancreatitis

Çavuşoğlu Türker B., AHBAB S., Türker F., HOCA E., Çiftçi Öztürk E., Kula A. C., et al.

Journal of Clinical Medicine , cilt.13, sa.12, 2024 (SCI-Expanded, Scopus)

14. Hypermagnesemia is associated with poor outcomes during hospitalization

HOCA E., Arat E. K., Arat O., AHBAB S., Kula A. C., Öztürk H., et al.

Irish Journal of Medical Science , cilt.193, sa.2, ss.733-739, 2024 (SCI-Expanded, Scopus)

15. Evaluation of Pulmonary Embolism Risk Stratification Scores in Patients Admitted to the Internal Medicine Clinic

Ercin E., HOCA E.

Haseki Tip Bulteni , cilt.62, sa.1, ss.41-46, 2024 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

16. Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index)

Turker B. C., Turker F., AHBAB S., HOCA E., Tahmaz M., ATAOĞLU H. E.

PLoS ONE , cilt.17, sa.3 March, 2022 (SCI-Expanded, Scopus)

17. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients

Cavuşoğlu Türker B., Türker F., AHBAB S., HOCA E., Urvasızoğlu A. O., Cetin S. I., et al.

International Journal of General Medicine , cilt.15, ss.6301-6307, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. The Assessment of Insulin Resistance and Triglyceride/Glucose Index in Nonalcoholic Fatty Liver Disease

CELIK M., Ahbab S., Hoca E., ATAOGLU H. E.

Southern Clinics of Istanbul Eurasia , cilt.32, sa.4, ss.381-387, 2021 (TRDizin)

Doç. Dr. Emre HOCA

Yayınlar & Eserler

1. Diagnostic Performance of Plasma Levels of sST2 (Soluble Suppression of Tumorigenicity 2) in the Evaluation of Hypervolemia in Hemodialysis Patients: A Comparative Analysis With Traditional and Alternative Biomarkers

2. Diyabetik olmayan aşırı kilolu/obez yetişkinlerde insülin direncinin belirleyicileri olarak bel-boyun oranı ve TG/HDL-C oranı: Kesitsel bir çalışma

3. Validity and Reliability of the Turkish Version of the Type 2 Diabetes Distress Assessment System (T2-DDAS-TR)

4. The Relationship Between Pituitary Axis Hormones and All-Cause Mortality in Hospitalized Patients with Chronic Diseases: A Prospective Cohort Study

5. Metabolic pathways are associated with increased estimated cardiovascular risk in major depressive disorder: a QRISK3-based analysis

6. Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis

7. The Effect of Visfatin Levels on Blood Pressure and Cardiac Risk Factors in Patients with Acromegaly

8. Low Serum Uric Acid as an Independent Predictor of Mortality and Poor Prognosis: A Retrospective Cohort Study

9. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients

10. The Impact of SGLT2 Inhibitors on Hemoglobin Levels in Type 2 Diabetes: Potential Benefits Beyond Glycemic and Renal Outcomes

11. The Impact of Metformin on BNP Levels: A Potential Cardioprotective Role in Type 2 Diabetes

12. The effects of chronic kidney disease stages on dyslipidemia, cardiovascular disease prevalence and mortality

13. Comparison of Controlling Nutritional Status Score with Bedside Index for Severity in Acute Pancreatitis Score and Atlanta Classification for Mortality in Patients with Acute Pancreatitis

14. Hypermagnesemia is associated with poor outcomes during hospitalization

15. Evaluation of Pulmonary Embolism Risk Stratification Scores in Patients Admitted to the Internal Medicine Clinic

16. Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index)

17. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients

18. The Assessment of Insulin Resistance and Triglyceride/Glucose Index in Nonalcoholic Fatty Liver Disease

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim